HCA Healthcare, Inc. (HCA) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $498.66. It has a SharesGrow Score of 61/100, indicating a above average investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of HCA = $621.48 (+24.6% from the current price, the stock appears undervalued). Analyst consensus target is HCA = $524 (+5.1% upside).
Valuation: HCA trades at a trailing Price-to-Earnings (P/E) of 17.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.72.
Financials: revenue is $75.6B, +7.9%/yr average growth. Net income is $6.8B, growing at +6.9%/yr. Net profit margin is 9% (thin). Gross margin is 41.5% (-42.9 pp trend).
Balance sheet: total debt is $50.2B with negative equity of -$6.0B — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.83 (tight liquidity). Debt-to-assets is 82.7%. Total assets: $60.7B.
Analyst outlook: 30 / 46 analysts rate HCA as buy (65%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 61/100 (Pass), Growth 65/100 (Pass), Past 100/100 (Pass), Health 25/100 (Fail), Moat 72/100 (Pass), Future 61/100 (Pass), Income 45/100 (Partial).
